Laura Sena
SKCCC Johns Hopkins Medical Institution · Johns Hopkins University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Laura Sena as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:52 UTC. Open this list on ClinicalTrials.gov
- N/ANCT06826924 · 7-Days Water-Only Fasting or Ketone Supplementation Trial in Prostate CancerSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · recruiting · Prostate Cancer, Prostate Cancer Metastatic · principal investigator
- Ph2NCT06059118 · Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate CancerSidney Kimmel Comprehensive Cancer Center at Johns Hopkins · recruiting · Prostate Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:52 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Synthetic lethal metabolic drug combinations for castration-resistant prostate cancerK08CA273167 · NCI · JOHNS HOPKINS UNIVERSITY · fiscal years 2023 to 2026 · $219,240 awarded in 2026Same name and institution; not confirmed by an ID
- A study of IDH1-mutant prostate cancer to identify novel therapeutic targetsR21CA292179 · NCI · JOHNS HOPKINS UNIVERSITY · fiscal years 2024 · $421,042 awarded in 2024Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:52 UTC. The ranking covers the 200 most relevant of 14 PubMed records, and a shared surname and initials can bring in a namesake. All 14 on PubMed
- Phase I clinical trial of weekly combretastatin A4 phosphate: clinical and pharmacokinetic results.J Clin Oncol · 2003272 citationsRCR 6.1
- A phase I trial of antibody directed enzyme prodrug therapy (ADEPT) in patients with advanced colorectal carcinoma or other CEA producing tumours.Br J Cancer · 2002106 citationsRCR 2.3
- Adjunct Targeted Biologic Inhibition Agents to Treat Aggressive Multivessel Intraluminal Pediatric Pulmonary Vein Stenosis.J Pediatr · 201878 citationsRCR 4.3
- A prospective phase II trial of vinblastine and methotrexate in multivessel intraluminal pulmonary vein stenosis in infants and children.Congenit Heart Dis · 201144 citationsRCR 1.5
- Bipolar androgen therapy plus nivolumab for patients with metastatic castration-resistant prostate cancer: the COMBAT phase II trial.Nat Commun · 202444 citationsRCR 5.3
- Steroid and cyclophosphamide in IgA nephropathy.Nephrol Dial Transplant · 200043 citationsRCR 1.2
- Bipolar androgen therapy sensitizes castration-resistant prostate cancer to subsequent androgen receptor ablative therapy.Eur J Cancer · 202140 citationsRCR 1.9
- 34 citationsRCR 1.3
- 24 citationsRCR 1.1
- 20 citationsRCR 0.9